🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
29445
CAS Number:
183552-38-7
Acétate d'abarelix
Documents
Available - Request Bulk Quote
Taille
Request Bulk Quote
Product Information

Abarelix acetate is a synthetic peptide compound primarily recognized for its role as a gonadotropin-releasing hormone (GnRH) antagonist. This compound is particularly significant in the field of oncology, where it is utilized for the treatment of advanced prostate cancer. By effectively inhibiting the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), Abarelix acetate helps to lower testosterone levels, which can slow the progression of hormone-sensitive tumors. Its unique mechanism of action makes it a valuable option for patients who may not be suitable candidates for surgical castration or other hormonal therapies.

In addition to its therapeutic applications, Abarelix acetate is of interest in research settings focused on hormone regulation and cancer treatment strategies. Its ability to provide rapid suppression of testosterone levels offers a distinct advantage over other treatments, allowing for quicker patient management. Researchers and healthcare professionals appreciate its efficacy and the potential for improved patient outcomes in managing hormone-dependent malignancies.

CAS Number
183552-38-7
Molecular Formula
C72H95ClN14O14 · C2H4O2
Molecular Weight
1476.13
MDL Number
MFCD17011970
PubChem ID
21879626
Conditions
Conserver à 0-8°C
General Information
CAS Number
183552-38-7
Molecular Formula
C72H95ClN14O14 · C2H4O2
Molecular Weight
1476.13
MDL Number
MFCD17011970
PubChem ID
21879626
Conditions
Conserver à 0-8°C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Abarelix acetate is widely utilized in research focused on

  • Prostate Cancer Treatment: This compound is primarily used in the treatment of advanced prostate cancer, providing an alternative to surgical castration. It works by inhibiting the release of luteinizing hormone, which in turn reduces testosterone levels that fuel cancer growth.
  • Clinical Trials: Abarelix acetate is often involved in clinical studies aimed at evaluating new therapies for hormone-sensitive cancers, helping researchers understand its efficacy and safety compared to other treatments.
  • Pharmaceutical Development: In the pharmaceutical industry, it serves as a reference compound for developing new anti-androgens, aiding in the formulation of medications that target similar pathways.
  • Research on Hormonal Regulation: The compound is used in laboratory settings to study hormonal regulation mechanisms, providing insights into how hormones affect various biological processes and diseases.
  • Comparative Effectiveness Research: It is also employed in studies comparing the effectiveness of different prostate cancer therapies, helping healthcare professionals make informed treatment decisions based on patient needs.

Citations